Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 17/20 | 0.69 |
| ▸ | ADRB1 | P08588 | 5/20 | 0.69 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.69 |
| ▸ | DRD2 | P14416 | 2/20 | 0.69 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.69 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.69 |
| ▸ | PGR | P06401 | 1/20 | 0.69 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.69 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.69 |
| ▸ | DRD3 | P35462 | 1/20 | 0.69 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL721150 | 1.00 | ADRB2 (0.69) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| SCHEMBL593753 | 1.00 | ADRB2 (0.69) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| SCHEMBL593754 | 1.00 | ADRB2 (0.69) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| SCHEMBL15271352 | 1.00 | ADRB2 (0.69) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| SCHEMBL29866225 | 1.00 | ADRB2 (0.69) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| SCHEMBL11810215 | 0.89 | ADRB2 (0.73) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| SCHEMBL4684534 | 0.89 | ADRA1A (0.71) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| SCHEMBL594466 | 0.86 | ADRB2 (0.70) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| SCHEMBL594467 | 0.86 | ADRB2 (0.70) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| Salmefamol SCHEMBL18458 | 0.85 | ADRB2 (0.67) | ADRB2ADRB1ADRB3DRD2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101636144-A | Inhalation formulations containing sulfoalkyl ether cyclodextrins and corticosteroids | CYDEX INC | 2010-01-27 | — | — | CN | claimed |
| CN-1976679-A | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid | CYDEX INC (US) | 2007-06-06 | — | — | CN | claimed |
| CN-1921830-A | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid | CYDEX INC (US) | 2007-02-28 | — | — | CN | claimed |
| CN-1921834-A | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension | CYDEX INC (US) | 2007-02-28 | — | — | CN | claimed |
| CN-102319231-A | The suction preparation that contains sulfoalkyl ether cyclodextrin and corticosteroid | CYDEX PHARMACEUTICALS INC | 2012-01-18 | — | — | CN | disclosed |
| CN-1976679-B | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid | CYDEX INC | 2011-08-31 | — | — | CN | disclosed |
| CN-101636144-A | Inhalation formulations containing sulfoalkyl ether cyclodextrins and corticosteroids | CYDEX INC | 2010-01-27 | — | — | CN | disclosed |
| CN-101098678-A | Dpi formulation containing sulfoalkyl ether cyclodextrin | CYDEX INC (US) | 2008-01-02 | — | — | CN | disclosed |
| CN-1976679-A | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid | CYDEX INC (US) | 2007-06-06 | — | — | CN | disclosed |
| CN-1921830-A | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid | CYDEX INC (US) | 2007-02-28 | — | — | CN | disclosed |
| CN-1921834-A | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension | CYDEX INC (US) | 2007-02-28 | — | — | CN | disclosed |